Replies to post #45481 on Cdex, Inc. (fka CDEX)

[Amanita]

CDEX 10 years ago!

THE WAY BACK MACHINE!

http://www.businesswire.com/news/home/20050126005642/en/University-Utah-Health-Sciences-Center-Addresses-Narcotics#.VZfcJ0bgiSp

ROCKVILLE, Md. & SALT LAKE CITY--(BUSINESS WIRE)--Jan. 26, 2005--Narcotic drug diversion

Man! That article is from the Malcolm Philips days, when CDEX was a real company with Doctors on staff, Engineers, Pharmacists, Med Techs, Lawyers, etc.. That was way, way back. Now it's some LOSER and his kid in a sucker search for money to keep their day SCAM jobs. But let's take a look....

"Looking forward, we expect to expand the use of ValiMed to all of our OR and oncology pharmacies," added Jorgenson. 'We are also interested in working with CDEX as they develop additional uses for their ValiMed products."

That didn't happen! The few Valimed's out there were the old bread box Valimed ones and two, and then the CCT. If those toys were successful, why aren't they still sold? The clear answer is that the Valimed was not a success and revisiting the history of the Valimed will not change that. The whole thing died when Baxa couldn't unload one, and made CDEX eat the returned machines, which were then parted out and sold on Ebay.

And here's the part still not figured out by some investors of the SCAM CDEX:

Any statements made in this press release which contain information that is not historical are essentially forward-looking. Forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, the ability of the Company to raise capital to finance the development of its chemical detection products, the effectiveness, profitability and the marketability of those products, the ability of the Company to protect its proprietary information, the establishment of an efficient corporate operating structure as the Company grows and, other risks detailed from time-to-time in our filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statements.